1. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
    , 2018, IJMS CrossRef
  2. Stem Cell Extracellular Vesicles in Skin Repair
    Andrea da Fonseca Ferreira et al, 2018, Bioengineering CrossRef
  3. Extracellular Vesicles–Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation
    Silvia Baldari et al, 2019, Cells CrossRef
  4. Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
    Hyo Jung Cho et al, 2020, JCM CrossRef
  5. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1


    Jing Yang et al, 2020, OTT CrossRef
  6. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma
    Mariam Mroweh et al, 2020, IJMS CrossRef
  7. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2
    Lei Yu et al, 2019, Aging CrossRef
  8. Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis
    Lang-Qing Sheng et al, 2020, WJGO CrossRef
  9. Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics
    Tomasz Lorenc et al, 2020, Cancers CrossRef
  10. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs
    Louie Semaan et al, 2021, Oncotarget CrossRef
  11. The AC006262.5–miR-7855-5p–BPY2C axis facilitates hepatocellular carcinoma proliferation and migration
    Fen-Rong Chen et al, 2020, Biochem. Cell Biol. CrossRef
  12. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases
    Seonghwan Hwang et al, 2021, Arch. Pharm. Res. CrossRef
  13. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study
    Qi Zhao et al, 2021, Disease Markers CrossRef
  14. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.
    Jin-Cui Yang et al, 2022, Front Oncol CrossRef
  15. Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25
    Haoming Lin et al, 2022, Front. Oncol. CrossRef
  16. Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma
    Shufang Yan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  17. Mesenchymal stem cells-based therapy in liver diseases
    Heng-Tong Han et al, 2022, Mol Biomed CrossRef
  18. Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma
    Jingwen Yang et al, 2022, Front. Cell Dev. Biol. CrossRef
  19. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
    Maria Pallozzi et al, 2022, Cancers CrossRef
  20. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.
    Amirsaeed S Aghabozorgi et al, 2019, J Cell Physiol CrossRef
  21. Serum Exosome-Derived piRNAs Could Be Promising Biomarkers for HCC Diagnosis
    Tao Rui et al, 2023, IJN CrossRef
  22. Non-destructive and efficient method for obtaining miRNA information in cells by artificial extracellular vesicles
    Fumio Maeda et al, 2023, Sci Rep CrossRef